WO2004053109A1 - Microorganism producing 5'xanthylic acid - Google Patents

Microorganism producing 5'xanthylic acid Download PDF

Info

Publication number
WO2004053109A1
WO2004053109A1 PCT/KR2003/002703 KR0302703W WO2004053109A1 WO 2004053109 A1 WO2004053109 A1 WO 2004053109A1 KR 0302703 W KR0302703 W KR 0302703W WO 2004053109 A1 WO2004053109 A1 WO 2004053109A1
Authority
WO
WIPO (PCT)
Prior art keywords
kccm
corynebacterium ammoniagenes
xanthylic acid
medium
cjxol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2003/002703
Other languages
French (fr)
Inventor
Young-Hyeon Kwag
Ki-Hoon Oh
Jeong-Hwan Kim
Yoon-Suk Oh
Jae-Ick Sim
Young-Hoon Park
Jea-Young Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ Corp
Original Assignee
CJ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ Corp filed Critical CJ Corp
Priority to US10/531,675 priority Critical patent/US7217558B2/en
Priority to MXPA05004142A priority patent/MXPA05004142A/en
Priority to EP03812725A priority patent/EP1570049A4/en
Priority to AU2003302756A priority patent/AU2003302756A1/en
Priority to BR0314902-1A priority patent/BR0314902A/en
Priority to BRPI0314902 priority patent/BRPI0314902B1/en
Priority to JP2004558538A priority patent/JP4177334B2/en
Publication of WO2004053109A1 publication Critical patent/WO2004053109A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/32—Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/15—Corynebacterium

Definitions

  • the invention relates to a microorganism producing 5'-xanthylic acid. More particularly, the invention relates to a mutant strain of Corynebacterium ammoniagenes KCCM 10340 having a resistance to oligomycin which inhibits ATP synthase activity and oxidative phosphorylation process, in order to enhance respiratory activity, making it possible to enhance ATP reproducing activity for same period of fermentation and accumulate 5'-xanthylic acid in culture medium at a high yield and high concentration rate.
  • 5'-xanthylic acid is an intermediate in the nucleic acid biosynthesis process, which is physiologically important in the body of animals and plants, used in food, medical supplies and other various field.
  • the invention relates to a mutant strain having a resistance to oligomycin, obtained from a known strain Corynebacterium ammoniagenes KCCM 10340, producing 5'-xanthylic acid at a high yield and high concentration rate by a direct fermentation method.
  • 5'-xanthylic acid is an intermediary product of purine nucleotide biosynthesis process and important material for producing 5'-guanylic acid.
  • a widely used method to produce 5'-guanylic acid having fineness and high quality is microorganism fermentation method which produces 5'-xanthylic acid first and converts it into 5'-guanylic acid enzymatically, therefore, to produce 5'-guanylic acid, corresponding amount of 5'-xanthylic acid is necessary.
  • the invention relates to Corynebacterium ammoniagenes CJXOL 0201 (KCCM- 10447) which is a mutant strain of Corynebacterium ammoniagenes KCCM 10340, producing 5'-xanthylic acid.
  • the CJXOL 0201 is obtained by treating Corynebacterium ammoniagenes KCCM 10340 with UV radiation and mutation derivatives such as N-methy-N'-nitro-n-nitrosoguanidine(NTG) according to ordinary procedure, and selecting a mutant strain among these which can grow in the culture medium (glucose 20g/L, potassium phosphate monobasic lg/L, potassium phosphate dibasic lg/L, urea 2g/L, ammonium sulfate 3g/L, magnesium sulfate lg/L, calcium chloride lOOmg/L, ferrous sulfate 20mg/L, manganese sulfate lOmg/L, zinc s
  • CJXOL 0201 A strain which can grow in 20mg/L oligomycin was separated, named CJXOL 0201, and it was deposited under Budapest Treaty to the Korean Culture Center of Microorganisms on November 21, 2002 with accession Number KCCM 10447.
  • the biochemical characteristic of the novel mutant strain CJXOL 0201 of the invention is shown in the following Table 1. According to the Table 1, the microorganism of the invention can grow in the medium which lOmg/L oligomycin was added into. The medium was fermented at 30 ° C for 5 days.
  • Seed medium glucose 30g/L, peptone 15g/L, yeast extract 15g/L, sodium chloride 2.5g/L, urea 3g/L, adenine 150mg/L, guanine 150mg/L, pH 7.2
  • Fermentation medium (1) A medium: glucose 60g/L, magnesium sulfate lOg/L, ferrous sulfate 20mg/L, zinc sulfate lOmg/L, manganese sulfate lOmg/L, adenine 30mg/L, guanine 30mg/L, biotin 100 ⁇ g/L, copper sulfate lmg/L, thiamine hydrochloride 5mg/L, calcium chloride lOmg/L, pH 7.2
  • B medium potassium phosphate monobasic lOg/L, potassium phosphate dibasic lOg/L, urea 7g/L, ammonium sulfate 5g/L
  • Fermentation method 5mL of the seed medium was poured into a test tube having diameter of 18mm and sterilized under pressure according to the common methods. After the sterilization, Corynebacterium ammoniagenes KCCM 10340 and Corynebacterium ammoniagenes CJXOL 0201 were seeded into respectively and it was cultured with shaking at 180rpm, 30 ° C for 18 hours. The resultant was used as seed culture.
  • a medium and B medium were sterilized separately under pressure according to the common methods and 29mL of A medium and lOmL of B medium were respectively poured into sterilized 500mL-Erlenmeyer flask for shaking and lmL of the above-mentioned seed culture was seeded into and fermented at 200rpm, 30 ° C for 90 hours.
  • the amount of accumulation of 5'-xanthylic acid in the medium showed that the amount in KCCM 10340 was 23.0g/L and the amount in CJXOL 0201 was 26.5g/L. (The concentration of accumulated 5'- xanthylic acid is given by 5'-sodium xanthate-7H 2 O.)
  • Primary seed medium same as the seed medium of example 1.
  • Secondary seed medium glucose 60g/L, potassium phosphate monobasic 2g/L, potassium phosphate dibasic 2g/L, magnesium sulfate lg/L, ferrous sulfate 22mg/L, zinc sulfate 15mg/L, manganese sulfate lOmg/L, copper sulfate lmg/L, calcium chloride lOOmg/L, biotin 150 g/L, adenine 150mg/L, guanine 150mg/L, thiamine hydrochloride 5mg/L, antifoaming agent 0.6mL/L, pH 7.2
  • Fermentation medium glucose 15 lg/L, phosphoric acid 32g/L, potassium hydroxide 25g/L, adenine 198mg/L, guanine 119mg/L, ferrous sulfate 60mg/L, zinc sulfate 42mg/L, manganese sulfate 15mg/L, copper sulfate 2.4mg/L, alaniate 22mg/L, NCA 7.5mg/L, biotin 0.4mg/L, magnesium sulfate 15g/L, cystinate 30mg/L, histidinate 30mg/L, calcium chloride 149mg/L, thiamine hydrochloride 15mg/L, antifoaming agent 0.7mL/L, CSL 27mL/L, tuna extract 6g/L, pH 7.3
  • Primary seed culture 50mL of the primary seed medium was poured into 500mL- Erlenmeyer flask for shaking and sterilized under pressure
  • Secondary seed culture The secondary seed medium was poured into 5L- experimental fermentation baths (2L each) and sterilized under pressure at 121 ° C for 10 minutes. After cooling, 50mL of the above primary seed culture was seeded and cultured with the air supply of 0.5wm, at 900rpm, 31 ° C , for 24 hours. During the cultunng process, the pH level of the medium was kept at 7.3 with adjusting by ammonia solution.
  • Fermentation method The fermentation medium was poured into 30L- experimental fermentation baths (8L each) and sterilized under pressure at 121 ° C for 20 minutes. After cooling, the above secondary seed culture was seeded into
  • the invention adopted Corynebacterium ammoniagenes KCCM 10340 as parent strain and treated it UV radiation or mutation derivatives such as N-methy- N'-nitro-n-nitrosoguanidine (NTG) according to ordinary procedure.
  • the KCCM 10340 strain has a resistance to osmotic pressure, caused by high concentration of 5 '-xanthylic acid accumulated during culturing process, high concentration of glucose and various carbon source added into culture medium, which results in the high osmotic pressure outside bacterial body, inhibition of normal physiological activity of 5 '-xanthylic acid-producing cell and decrease of 5'- xanthylic acid production.
  • the invention modified Corynebacterium ammoniagenes KCCM 10340 and selected a mutant strain having a resistance to oligomycin which inhibits ATP synthase activity and oxidative phosphorylation process, and makes it possible to enhance ATP reproducing activity and to accumulate 5 '-xanthylic acid in culture medium at a high yield and high concentration rate for same period of fermentation.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to Corynebacterium ammoniagenes CJXOL 0201 KCCM 10447 producing 5'-xanthylic acid. More specifically, the invention relates to Corynebacterium ammoniagenes CJXOL 0201 KCCM 10447 which is a mutant strain of Corynebacterium ammoniagenes KCCM 10340 having a resistance to oligomycin. In order to obtain mutant strain having enhanced respiratory activity, the present invention adopted Corynebacterium ammoniagenes KCCM 10340 as parent strain and treated it with UV radiation and mutation derivatives such as N-methyl-N'-nitro-n-nitrosoguanidine(NTG) according to ordinary procedure. Therefore, Corynebacterium ammoniagenes CJXOL 0201 KCCM 10447 of the present invention makes it possible to increase ATP reproducing activity for same period of fermentation and can accumulate 5'xanthylic acid in culture medium at a high yield and concentration rate.

Description

MICROORGANISM PRODUCING 5'-XANTHYLIC ACID
Technical Field
The invention relates to a microorganism producing 5'-xanthylic acid. More particularly, the invention relates to a mutant strain of Corynebacterium ammoniagenes KCCM 10340 having a resistance to oligomycin which inhibits ATP synthase activity and oxidative phosphorylation process, in order to enhance respiratory activity, making it possible to enhance ATP reproducing activity for same period of fermentation and accumulate 5'-xanthylic acid in culture medium at a high yield and high concentration rate.
Background Art
5'-xanthylic acid is an intermediate in the nucleic acid biosynthesis process, which is physiologically important in the body of animals and plants, used in food, medical supplies and other various field. The invention relates to a mutant strain having a resistance to oligomycin, obtained from a known strain Corynebacterium ammoniagenes KCCM 10340, producing 5'-xanthylic acid at a high yield and high concentration rate by a direct fermentation method.
5'-xanthylic acid is an intermediary product of purine nucleotide biosynthesis process and important material for producing 5'-guanylic acid. A widely used method to produce 5'-guanylic acid having fineness and high quality is microorganism fermentation method which produces 5'-xanthylic acid first and converts it into 5'-guanylic acid enzymatically, therefore, to produce 5'-guanylic acid, corresponding amount of 5'-xanthylic acid is necessary. Conventional methods to produce 5'-xanthylic acid are chemosynthesis, deaminization of 5'- guanylic acid which is produced as a result of decomposition of ribonucleic acid in yeast, a fermentation method to add xanthine as precursor material in fermenting medium, a fermentation method to use a mutant strain of microorganism, a method to add antibiotic material (JP 1477/42 and JP 20390/44), a method to add surfactant (JP 3825/42 and JP 3838/42) and so on. Among these, a direct fermentation method of 5'-xanthylic acid by a mutant strain of microorganism is quite advantageous in terms of industrial aspect. Thus, we inventors developed a mutant strain with increased productivity of 5'-xanthylic acid, by modifying the existing character of Corynebacterium ammoniagenes KCCM 10340 into the character of producing 5'-xanthylic acid at a large yield rate. Most microorganisms reach to the condition that the volume doesn't increase any more when keep on culturing under the constant condition, and especially the concentration of microorganism producing primary metabolite, a growth-dependent product, doesn't increase any more. It is mainly caused by limited supply of dissolved oxygen. Method of enhancing aeration and agitation condition, for removal of the limited supply of dissolved oxygen, is used, but there is technical and economical limit in actual production method. To overcome the limit and increase yield rate and concentration of 5'-xanthylic acid by enhancing, the volume of microorganism and various physiological activity, under the limited supply of dissolved oxygen, we inventors thought that the method of enhancing respiratory activity and ATP reproducing activity of microorganism under the same dissolved oxygen would be useful. Thus, the inventors investigated microorganism strains having a resistance to various respiratory inhibitors, and found out that a mutant strain having a resistance to oligomycin is most effective among these and can produce 5'-xanthylic acid at a high yield and high concentration rate by a direct fermentation method, and accomplished in this invention. Disclosure of the Invention
The invention relates to Corynebacterium ammoniagenes CJXOL 0201 (KCCM- 10447) which is a mutant strain of Corynebacterium ammoniagenes KCCM 10340, producing 5'-xanthylic acid. The CJXOL 0201 is obtained by treating Corynebacterium ammoniagenes KCCM 10340 with UV radiation and mutation derivatives such as N-methy-N'-nitro-n-nitrosoguanidine(NTG) according to ordinary procedure, and selecting a mutant strain among these which can grow in the culture medium (glucose 20g/L, potassium phosphate monobasic lg/L, potassium phosphate dibasic lg/L, urea 2g/L, ammonium sulfate 3g/L, magnesium sulfate lg/L, calcium chloride lOOmg/L, ferrous sulfate 20mg/L, manganese sulfate lOmg/L, zinc sulfate lOmg/L, biotin 30/zg/L, thiamine hydrochloride O.lmg/L, copper sulfate 0.8mg/L, adenine 20mg/L, guanine 20mg/L, pH 7.2) which different concentration levels of oligomycin (1,2,5, 10,20,50mg/L) is added into. In the procedure, 0~50mg/L oligomycin was added into the medium and there showed a resistance up to 20mg/L oligomycin but no growth was observed at the concentration level above 20mg/L. A strain which can grow in 20mg/L oligomycin was separated, named CJXOL 0201, and it was deposited under Budapest Treaty to the Korean Culture Center of Microorganisms on November 21, 2002 with accession Number KCCM 10447. The biochemical characteristic of the novel mutant strain CJXOL 0201 of the invention is shown in the following Table 1. According to the Table 1, the microorganism of the invention can grow in the medium which lOmg/L oligomycin was added into. The medium was fermented at 30 °C for 5 days.
Table 1
Strain Oligomycin Concentraion (mg/L)
0 5 10 20 30 40 50
Figure imgf000005_0001
+ : growth, - : no growth
BEST MODE FOR CARRYING OUT THE INVENTION Example 1
Used strains: Corynebacterium ammoniagenes KCCM 10340, Corynebacterium ammoniagenes CJXOL 0201
Seed medium: glucose 30g/L, peptone 15g/L, yeast extract 15g/L, sodium chloride 2.5g/L, urea 3g/L, adenine 150mg/L, guanine 150mg/L, pH 7.2
Fermentation medium: (1) A medium: glucose 60g/L, magnesium sulfate lOg/L, ferrous sulfate 20mg/L, zinc sulfate lOmg/L, manganese sulfate lOmg/L, adenine 30mg/L, guanine 30mg/L, biotin 100μg/L, copper sulfate lmg/L, thiamine hydrochloride 5mg/L, calcium chloride lOmg/L, pH 7.2
(2) B medium: potassium phosphate monobasic lOg/L, potassium phosphate dibasic lOg/L, urea 7g/L, ammonium sulfate 5g/L
Fermentation method: 5mL of the seed medium was poured into a test tube having diameter of 18mm and sterilized under pressure according to the common methods. After the sterilization, Corynebacterium ammoniagenes KCCM 10340 and Corynebacterium ammoniagenes CJXOL 0201 were seeded into respectively and it was cultured with shaking at 180rpm, 30 °C for 18 hours. The resultant was used as seed culture. Then, as fermentation medium, A medium and B medium were sterilized separately under pressure according to the common methods and 29mL of A medium and lOmL of B medium were respectively poured into sterilized 500mL-Erlenmeyer flask for shaking and lmL of the above-mentioned seed culture was seeded into and fermented at 200rpm, 30 °C for 90 hours. After the fermentation was completed, the amount of accumulation of 5'-xanthylic acid in the medium showed that the amount in KCCM 10340 was 23.0g/L and the amount in CJXOL 0201 was 26.5g/L. (The concentration of accumulated 5'- xanthylic acid is given by 5'-sodium xanthate-7H2O.)
Example 2
Used strains: same as example 1.
Primary seed medium: same as the seed medium of example 1.
Secondary seed medium: glucose 60g/L, potassium phosphate monobasic 2g/L, potassium phosphate dibasic 2g/L, magnesium sulfate lg/L, ferrous sulfate 22mg/L, zinc sulfate 15mg/L, manganese sulfate lOmg/L, copper sulfate lmg/L, calcium chloride lOOmg/L, biotin 150 g/L, adenine 150mg/L, guanine 150mg/L, thiamine hydrochloride 5mg/L, antifoaming agent 0.6mL/L, pH 7.2
Fermentation medium: glucose 15 lg/L, phosphoric acid 32g/L, potassium hydroxide 25g/L, adenine 198mg/L, guanine 119mg/L, ferrous sulfate 60mg/L, zinc sulfate 42mg/L, manganese sulfate 15mg/L, copper sulfate 2.4mg/L, alaniate 22mg/L, NCA 7.5mg/L, biotin 0.4mg/L, magnesium sulfate 15g/L, cystinate 30mg/L, histidinate 30mg/L, calcium chloride 149mg/L, thiamine hydrochloride 15mg/L, antifoaming agent 0.7mL/L, CSL 27mL/L, tuna extract 6g/L, pH 7.3 Primary seed culture: 50mL of the primary seed medium was poured into 500mL- Erlenmeyer flask for shaking and sterilized under pressure at 121 °C for 20 minutes. After cooling, Coiγnebacterium ammoniagenes KCCM 10340 and Corynebacterium ammoniagenes CJXOL 0201 were seeded into respectively and it was cultured with shaking at 180rpm, 30 °C for 24 hours.
Secondary seed culture: The secondary seed medium was poured into 5L- experimental fermentation baths (2L each) and sterilized under pressure at 121 °C for 10 minutes. After cooling, 50mL of the above primary seed culture was seeded and cultured with the air supply of 0.5wm, at 900rpm, 31 °C , for 24 hours. During the cultunng process, the pH level of the medium was kept at 7.3 with adjusting by ammonia solution.
Fermentation method: The fermentation medium was poured into 30L- experimental fermentation baths (8L each) and sterilized under pressure at 121 °C for 20 minutes. After cooling, the above secondary seed culture was seeded into
(1.5L each) and cultured with the air supply of lvvm, at 400rpm, 33 °C . Whenever the residual sugar level drops below 1% during the cultunng process, sterilized glucose was supplied and the total sugar level in the fermentation medium was kept at 30%. During the culturing process, the pH level of the medium was kept at
7.3 with adjusting by ammonia solution and the process took 90 hours. After the fermentation was completed, the amount of accumulation of 5'-xanthylic acid in the medium showed that the amount in KCCM 10340 was 137.2g/L and the amount in CJXOL 0201 was 148.4g/L. (The concentration of accumulated 5'- xanthylic acid is given by 5'-sodium xanthate-7H2O.) Industrial Applicability
The invention adopted Corynebacterium ammoniagenes KCCM 10340 as parent strain and treated it UV radiation or mutation derivatives such as N-methy- N'-nitro-n-nitrosoguanidine (NTG) according to ordinary procedure. The KCCM 10340 strain has a resistance to osmotic pressure, caused by high concentration of 5 '-xanthylic acid accumulated during culturing process, high concentration of glucose and various carbon source added into culture medium, which results in the high osmotic pressure outside bacterial body, inhibition of normal physiological activity of 5 '-xanthylic acid-producing cell and decrease of 5'- xanthylic acid production. In order to obtain a strain having enhanced character of osmotic pressure resistance and enhanced respiratory activity, the invention modified Corynebacterium ammoniagenes KCCM 10340 and selected a mutant strain having a resistance to oligomycin which inhibits ATP synthase activity and oxidative phosphorylation process, and makes it possible to enhance ATP reproducing activity and to accumulate 5 '-xanthylic acid in culture medium at a high yield and high concentration rate for same period of fermentation.

Claims

WHAT IS CLAIMED IS:
1. Corynebacterium ammoniagenes CJXOL 0201 (Accession Number: KCCM 10447) having a resistance to oligomycin and producing 5'- xanthylic acid.
2. A method of producing 5 '-xanthylic acid characterized by using Corynebacterium ammoniagenes CJXOL 0201 (Accession Number: KCCM 10447) of claim 1.
PCT/KR2003/002703 2002-12-11 2003-12-10 Microorganism producing 5'xanthylic acid Ceased WO2004053109A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US10/531,675 US7217558B2 (en) 2002-12-11 2003-12-10 Microorganism producing 5'xanthylic acid
MXPA05004142A MXPA05004142A (en) 2002-12-11 2003-12-10 Microorganism producing 5'xanthylic acid.
EP03812725A EP1570049A4 (en) 2002-12-11 2003-12-10 MICROORGANISM PRODUCING 5'-XANTHYLIC ACID
AU2003302756A AU2003302756A1 (en) 2002-12-11 2003-12-10 Microorganism producing 5'xanthylic acid
BR0314902-1A BR0314902A (en) 2002-12-11 2003-12-10 Method for Producing 5'-Xanthlic Acid
BRPI0314902 BRPI0314902B1 (en) 2002-12-11 2003-12-10 method for producing 5'-xanthyl acid
JP2004558538A JP4177334B2 (en) 2002-12-11 2003-12-10 Microorganism producing 5'-xanthylic acid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2002-0078693 2002-12-11
KR10-2002-0078693A KR100505925B1 (en) 2002-12-11 2002-12-11 Microorganism producing 5’-Xanthylic acid

Publications (1)

Publication Number Publication Date
WO2004053109A1 true WO2004053109A1 (en) 2004-06-24

Family

ID=36117094

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2003/002703 Ceased WO2004053109A1 (en) 2002-12-11 2003-12-10 Microorganism producing 5'xanthylic acid

Country Status (10)

Country Link
US (1) US7217558B2 (en)
EP (1) EP1570049A4 (en)
JP (1) JP4177334B2 (en)
KR (1) KR100505925B1 (en)
CN (1) CN100366729C (en)
AU (1) AU2003302756A1 (en)
BR (2) BRPI0314902B1 (en)
MX (1) MXPA05004142A (en)
RU (1) RU2312140C2 (en)
WO (1) WO2004053109A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006059877A1 (en) * 2004-12-01 2006-06-08 Cj Corporation Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040051731A (en) * 2002-12-11 2004-06-19 씨제이 주식회사 Microorganism producing 5’-Xanthylic acid
KR100959662B1 (en) * 2008-01-04 2010-05-26 씨제이제일제당 (주) Corynebacterium microorganisms having inosine production ability and production method of inosine using the same
KR101072708B1 (en) * 2008-12-17 2011-10-11 씨제이제일제당 (주) A corynebacteria having enhanced 5'-xanthosine monophosphate productivity and a method of producing 5'-xanthosine monophosphate using the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5978687A (en) * 1982-09-28 1984-05-07 マイルス・ラボラトリ−ス・インコ−ポレ−テツド Immobilized enzyme combination
EP0350970A1 (en) * 1983-02-25 1990-01-17 Kyowa Hakko Kogyo Co., Ltd. Process for producing L-glutamic acid by fermentation and mutant microorganisms for use therein
JP2000295996A (en) * 1999-02-08 2000-10-24 Kyowa Hakko Kogyo Co Ltd Purine nucleotide production method
KR20010089980A (en) * 2000-04-08 2001-10-17 손 경 식 5'-Xanthylic acid producing microorganism
KR20020057470A (en) * 2001-01-05 2002-07-11 손 경 식 A microorganism Corynebacterium ammoniagenes NV4-82-9 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2203948C2 (en) * 1999-10-28 2003-05-10 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" Strain of bacterium corynebacterium ammoniagenes as producer of uridine-5'-monophosphate (variants), method for preparing uridine-5'-monophosphate
RU2209249C2 (en) * 2000-11-22 2003-07-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" Method for preparing xanthosine 5'-monophosphate, strain corynebacterium ammoniagenes as producer of xanthosine 5'-monophosphate (variants)

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5978687A (en) * 1982-09-28 1984-05-07 マイルス・ラボラトリ−ス・インコ−ポレ−テツド Immobilized enzyme combination
EP0350970A1 (en) * 1983-02-25 1990-01-17 Kyowa Hakko Kogyo Co., Ltd. Process for producing L-glutamic acid by fermentation and mutant microorganisms for use therein
JP2000295996A (en) * 1999-02-08 2000-10-24 Kyowa Hakko Kogyo Co Ltd Purine nucleotide production method
KR20010089980A (en) * 2000-04-08 2001-10-17 손 경 식 5'-Xanthylic acid producing microorganism
KR20020057470A (en) * 2001-01-05 2002-07-11 손 경 식 A microorganism Corynebacterium ammoniagenes NV4-82-9 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1570049A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006059877A1 (en) * 2004-12-01 2006-06-08 Cj Corporation Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same

Also Published As

Publication number Publication date
US20060154346A1 (en) 2006-07-13
EP1570049A4 (en) 2006-05-10
JP2006502740A (en) 2006-01-26
KR100505925B1 (en) 2005-08-03
EP1570049A1 (en) 2005-09-07
RU2312140C2 (en) 2007-12-10
US7217558B2 (en) 2007-05-15
JP4177334B2 (en) 2008-11-05
MXPA05004142A (en) 2005-10-05
RU2005111595A (en) 2006-03-20
BRPI0314902B1 (en) 2019-11-26
CN100366729C (en) 2008-02-06
CN1708581A (en) 2005-12-14
KR20040051730A (en) 2004-06-19
AU2003302756A1 (en) 2004-06-30
BR0314902A (en) 2005-08-02

Similar Documents

Publication Publication Date Title
EP2041265A1 (en) Method for producing l-arginine using corynebacterium glutamicum
US7608435B2 (en) Microorganism producing 5′-xanthylic acid
EP1572982B1 (en) Microorganism producing 5 -xanthylic acid
KR100402320B1 (en) A microorganism Corynebacterium ammoniagenes NV4-82-9 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same
EP1570049A1 (en) Microorganism producing 5 xanthylic acid
KR100344016B1 (en) 5'-Xanthylic acid producing microorganism
KR100344018B1 (en) 5'-Xanthylic acid producing microorganism
KR100402322B1 (en) A microorganism Corynebacterium ammoniagenes CJXP002 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same
KR100588578B1 (en) 5'-Xanthyl Acid Producing Microorganism and Production Method of 5'-Xanthyl Acid Using the Same
KR100588577B1 (en) Microorganisms that produce 5′-inosinic acid and methods of producing 5′-inosine acid using the same
KR100429926B1 (en) Microorganism overproducing 5’-xanthylic acid
KR970002252B1 (en) Microorganisms Producing 5'-Xanthyl Acid
KR20020057471A (en) A microorganism Corynebacterium ammoniagenes Az120-62-25 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 1200500541

Country of ref document: VN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003812725

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2006154346

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10531675

Country of ref document: US

Ref document number: 2004558538

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/004142

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 20038A19452

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2005111595

Country of ref document: RU

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2003812725

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10531675

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2003812725

Country of ref document: EP